18.59
price down icon1.90%   -0.36
after-market 시간 외 거래: 17.93 -0.66 -3.55%
loading
전일 마감가:
$18.95
열려 있는:
$18.17
하루 거래량:
633.07K
Relative Volume:
0.66
시가총액:
$576.23M
수익:
$17.16M
순이익/손실:
$-163.62M
주가수익비율:
-3.0576
EPS:
-6.08
순현금흐름:
$-121.61M
1주 성능:
-0.64%
1개월 성능:
+10.52%
6개월 성능:
-44.51%
1년 성능:
-17.45%
1일 변동 폭
Value
$17.83
$18.80
1주일 범위
Value
$17.50
$19.60
52주 변동 폭
Value
$12.21
$41.31

Anaptysbio Inc Stock (ANAB) Company Profile

Name
명칭
Anaptysbio Inc
Name
전화
858-362-6295
Name
주소
10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA
Name
직원
136
Name
트위터
@anaptysbio
Name
다음 수익 날짜
2024-11-08
Name
최신 SEC 제출 서류
Name
ANAB's Discussions on Twitter

ANAB을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
ANAB
Anaptysbio Inc
18.59 576.23M 17.16M -163.62M -121.61M -6.08
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.82 131.41B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
634.23 72.26B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
591.87 36.10B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
270.02 35.03B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
272.17 28.24B 3.81B -644.79M -669.77M -6.24

Anaptysbio Inc Stock (ANAB) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-02-04 개시 Wolfe Research Outperform
2024-12-11 다운그레이드 H.C. Wainwright Buy → Neutral
2024-12-02 다운그레이드 BTIG Research Buy → Neutral
2024-07-22 개시 H.C. Wainwright Buy
2024-07-19 업그레이드 JP Morgan Neutral → Overweight
2024-04-16 개시 Leerink Partners Outperform
2024-04-11 개시 Wells Fargo Overweight
2024-03-12 업그레이드 Wedbush Neutral → Outperform
2024-02-26 개시 BTIG Research Buy
2024-02-21 개시 Stifel Buy
2024-02-16 개시 Piper Sandler Overweight
2023-05-22 업그레이드 JP Morgan Underweight → Neutral
2023-05-18 개시 TD Cowen Outperform
2023-01-06 다운그레이드 Raymond James Outperform → Mkt Perform
2022-11-01 업그레이드 Guggenheim Neutral → Buy
2022-09-19 재개 H.C. Wainwright Buy
2022-09-13 다운그레이드 Truist Buy → Hold
2022-09-01 개시 Raymond James Outperform
2022-03-22 다운그레이드 Guggenheim Buy → Neutral
2021-06-22 개시 H.C. Wainwright Buy
2021-05-21 개시 UBS Neutral
2021-03-16 업그레이드 Truist Hold → Buy
2021-03-09 다운그레이드 Wedbush Outperform → Neutral
2021-03-08 다운그레이드 JP Morgan Overweight → Underweight
2021-02-11 업그레이드 JP Morgan Underweight → Overweight
2020-10-27 업그레이드 Wedbush Neutral → Outperform
2020-10-14 업그레이드 Guggenheim Neutral → Buy
2019-11-08 다운그레이드 JP Morgan Overweight → Underweight
2019-11-08 다운그레이드 Jefferies Buy → Hold
2019-11-08 다운그레이드 SunTrust Buy → Hold
2019-11-08 다운그레이드 Wedbush Outperform → Neutral
2019-06-21 다운그레이드 Credit Suisse Outperform → Neutral
2019-06-21 다운그레이드 Stifel Buy → Hold
2018-12-20 개시 H.C. Wainwright Buy
2018-11-21 개시 JP Morgan Overweight
2018-07-19 개시 Credit Suisse Outperform
2018-04-04 다운그레이드 RBC Capital Mkts Outperform → Sector Perform
2018-03-27 재확인 Stifel Buy
2018-03-06 재확인 Stifel Buy
2018-02-15 재확인 SunTrust Buy
2018-01-23 재확인 Credit Suisse Outperform
2017-11-15 개시 SunTrust Buy
2017-11-09 개시 Jefferies Buy
2017-10-11 재확인 RBC Capital Mkts Outperform
2017-09-15 개시 RBC Capital Mkts Outperform
모두보기

Anaptysbio Inc 주식(ANAB)의 최신 뉴스

pulisher
Mar 29, 2025

AnaptysBio (NASDAQ:ANAB) Trading Up 2.5%What's Next? - MarketBeat

Mar 29, 2025
pulisher
Mar 29, 2025

How to Take Advantage of moves in (ANAB) - news.stocktradersdaily.com

Mar 29, 2025
pulisher
Mar 29, 2025

AnaptysBio (NASDAQ:ANAB) Shares Gap UpShould You Buy? - MarketBeat

Mar 29, 2025
pulisher
Mar 29, 2025

Charles Schwab Investment Management Inc. Acquires 5,733 Shares of AnaptysBio, Inc. (NASDAQ:ANAB) - Defense World

Mar 29, 2025
pulisher
Mar 29, 2025

AnaptysBio (NASDAQ:ANAB) Trading Down 4.1%Should You Sell? - MarketBeat

Mar 29, 2025
pulisher
Mar 28, 2025

AnaptysBio (NASDAQ:ANAB) to Repurchase $75.00 million in Stock - MarketBeat

Mar 28, 2025
pulisher
Mar 27, 2025

Leerink Partners Sticks to Their Buy Rating for AnaptysBio (ANAB) - The Globe and Mail

Mar 27, 2025
pulisher
Mar 26, 2025

AnaptysBio, Inc. (NASDAQ:ANAB) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat

Mar 26, 2025
pulisher
Mar 25, 2025

AnaptysBio (ANAB) Moves 9.5% Higher: Will This Strength Last? - MSN

Mar 25, 2025
pulisher
Mar 25, 2025

AnaptysBio (NASDAQ:ANAB) to Repurchase $75.00 million in Shares - Defense World

Mar 25, 2025
pulisher
Mar 24, 2025

AnaptysBio Shares Jump on Buyback Program Authorization - MarketWatch

Mar 24, 2025
pulisher
Mar 24, 2025

Crude Oil Gains 1%; US Composite PMI Surges In March - Benzinga

Mar 24, 2025
pulisher
Mar 24, 2025

Anaptys Announces Stock Repurchase Plan - GlobeNewswire

Mar 24, 2025
pulisher
Mar 24, 2025

AnaptysBio authorizes $75 million stock buyback plan By Investing.com - Investing.com South Africa

Mar 24, 2025
pulisher
Mar 24, 2025

Anaptys announces $75 million stock repurchase plan - MSN

Mar 24, 2025
pulisher
Mar 24, 2025

AnaptysBio Announces $75 Mln Stock Repurchase Plan - Nasdaq

Mar 24, 2025
pulisher
Mar 24, 2025

AnaptysBio stock rises following stock repurchase plan By Investing.com - Investing.com Canada

Mar 24, 2025
pulisher
Mar 24, 2025

Intuitive Machines Posts Q4 Results, Joins Tesla, AnaptysBio, Coherent And Other Big Stocks Moving Higher On Monday - Benzinga

Mar 24, 2025
pulisher
Mar 24, 2025

AnaptysBio Approves $75 Million Buyback Plan; Shares Rise -March 24, 2025 at 09:50 am EDT - Marketscreener.com

Mar 24, 2025
pulisher
Mar 24, 2025

AnaptysBio authorizes $75 million stock buyback plan - Investing.com India

Mar 24, 2025
pulisher
Mar 24, 2025

AnaptysBio, Inc. Authorizes $75 Million Stock Repurchase Plan - Nasdaq

Mar 24, 2025
pulisher
Mar 24, 2025

AnaptysBio (NASDAQ:ANAB) Stock Price Up 4.4%What's Next? - MarketBeat

Mar 24, 2025
pulisher
Mar 22, 2025

AnaptysBio, Inc. (NASDAQ:ANAB) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World

Mar 22, 2025
pulisher
Mar 21, 2025

AlphaQuest LLC Purchases 4,237 Shares of AnaptysBio, Inc. (NASDAQ:ANAB) - Defense World

Mar 21, 2025
pulisher
Mar 19, 2025

AnaptysBio, Inc. (NASDAQ:ANAB) Position Raised by Victory Capital Management Inc. - MarketBeat

Mar 19, 2025
pulisher
Mar 16, 2025

Victory Capital Management Inc. Purchases 97,200 Shares of AnaptysBio, Inc. (NASDAQ:ANAB) - Defense World

Mar 16, 2025
pulisher
Mar 15, 2025

Wells Fargo Predicts Up to ~440% Rally for These 2 ‘Strong Buy’ Stocks - Markets Insider

Mar 15, 2025
pulisher
Mar 10, 2025

AnaptysBio (NASDAQ:ANAB) Price Target Raised to $42.00 - MarketBeat

Mar 10, 2025
pulisher
Mar 09, 2025

Rhumbline Advisers Grows Position in AnaptysBio, Inc. (NASDAQ:ANAB) - Defense World

Mar 09, 2025
pulisher
Mar 08, 2025

HC Wainwright Reaffirms Neutral Rating for AnaptysBio (NASDAQ:ANAB) - MarketBeat

Mar 08, 2025
pulisher
Mar 08, 2025

When (ANAB) Moves Investors should Listen - Stock Traders Daily

Mar 08, 2025
pulisher
Mar 07, 2025

Y Intercept Hong Kong Ltd Purchases Shares of 23,497 AnaptysBio, Inc. (NASDAQ:ANAB) - MarketBeat

Mar 07, 2025
pulisher
Mar 07, 2025

AnaptysBio (NASDAQ:ANAB) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says - Defense World

Mar 07, 2025
pulisher
Mar 06, 2025

Leerink Partnrs Weighs in on AnaptysBio FY2029 Earnings - MarketBeat

Mar 06, 2025
pulisher
Mar 06, 2025

AnaptysBio (ANAB) to Release Quarterly Earnings on Monday - MarketBeat

Mar 06, 2025
pulisher
Mar 06, 2025

AnaptysBio: A Shadow Of Its Former Self (NASDAQ:ANAB) - Seeking Alpha

Mar 06, 2025
pulisher
Mar 05, 2025

Palmoplantar Pustulosis Clinical and Non-Clinical Studies, - openPR

Mar 05, 2025
pulisher
Mar 05, 2025

AnaptysBio’s (ANAB) Neutral Rating Reaffirmed at HC Wainwright - Defense World

Mar 05, 2025
pulisher
Mar 05, 2025

AnaptysBio, Inc. (NASDAQ:ANAB) Short Interest Update - MarketBeat

Mar 05, 2025
pulisher
Mar 04, 2025

AnaptysBio (NASDAQ:ANAB) Shares Gap Up Following Strong Earnings - MarketBeat

Mar 04, 2025
pulisher
Mar 04, 2025

H.C. Wainwright maintains AnaptysBio stock Neutral with $22 target By Investing.com - Investing.com Canada

Mar 04, 2025

Anaptysbio Inc (ANAB) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$70.69
price down icon 1.05%
$76.29
price down icon 2.18%
$31.13
price down icon 0.77%
$19.29
price down icon 5.07%
$91.06
price down icon 4.10%
biotechnology ONC
$272.17
price up icon 1.79%
자본화:     |  볼륨(24시간):